Asset Management One Co. Ltd. Sells 3,952 Shares of Kenvue Inc. $KVUE

Asset Management One Co. Ltd. cut its stake in shares of Kenvue Inc. (NYSE:KVUE) by 0.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 797,424 shares of the company’s stock after selling 3,952 shares during the period. Asset Management One Co. Ltd.’s holdings in Kenvue were worth $16,690,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. increased its position in shares of Kenvue by 4.0% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 106,140 shares of the company’s stock valued at $2,545,000 after buying an additional 4,034 shares during the period. Renaissance Capital LLC increased its position in shares of Kenvue by 8.3% in the second quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock worth $13,169,000 after purchasing an additional 48,267 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of Kenvue by 80.7% in the second quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock worth $758,000 after purchasing an additional 16,164 shares during the last quarter. Arlington Partners LLC bought a new position in shares of Kenvue in the second quarter worth approximately $2,110,000. Finally, Cornell Pochily Investment Advisors Inc. increased its position in shares of Kenvue by 144.6% in the second quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock worth $694,000 after purchasing an additional 19,609 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on KVUE shares. Redburn Partners set a $22.00 price objective on shares of Kenvue in a research report on Friday, September 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Tuesday, October 14th. Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and decreased their price objective for the stock from $22.50 to $22.00 in a research report on Friday, September 26th. Evercore ISI decreased their price objective on shares of Kenvue from $23.00 to $18.00 and set an “in-line” rating on the stock in a research report on Tuesday, September 23rd. Finally, Canaccord Genuity Group reduced their price target on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Kenvue currently has an average rating of “Hold” and a consensus target price of $20.75.

Kenvue Stock Down 0.6%

Shares of NYSE KVUE opened at $15.00 on Friday. Kenvue Inc. has a one year low of $14.05 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The firm’s 50 day simple moving average is $17.91 and its two-hundred day simple moving average is $20.79. The stock has a market capitalization of $28.78 billion, a P/E ratio of 20.26, a PEG ratio of 2.16 and a beta of 0.72.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The business had revenue of $3.84 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period last year, the business earned $0.32 earnings per share. The business’s quarterly revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.5%. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue’s payout ratio is currently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.